Six of 13 outpatients with schizophrenia who participated in a ten-week open trial of risperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and depression and periods of crying and insomnia.
periods of crying
risperidone
depression
risperidone
feelings of agitation
risperidone
insomnia
risperidone
intolerable affect
risperidone